etomoxir has been researched along with 2,5-anhydromannitol in 1 studies
| Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (2,5-anhydromannitol) | Trials (2,5-anhydromannitol) | Recent Studies (post-2010) (2,5-anhydromannitol) |
|---|---|---|---|---|---|
| 260 | 8 | 93 | 63 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedman, MI; Horn, CC; Ji, H | 1 |
1 other study(ies) available for etomoxir and 2,5-anhydromannitol
| Article | Year |
|---|---|
Etomoxir, a fatty acid oxidation inhibitor, increases food intake and reduces hepatic energy status in rats.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Eating; Energy Metabolism; Enzyme Inhibitors; Epoxy Compounds; Liver; Male; Mannitol; Oxidation-Reduction; Propionates; Rats; Rats, Sprague-Dawley | 2004 |